Investor presentationSep 2026
Sep 2026 · PPT
Source: Nse
Ambani Orgochem Ltd. (AMBANIORGO)
SME CapIndustrials stocks · SME cap · NSE
Ambani Orgochem Ltd. operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
₹178.2
+8.45 · +4.98%
Market cap ₹147 Cr
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:15 pm ISTDetails
Quote19 Oct, 03:15 pm IST
Base fundamentals16 Oct 2026 · screener
Latest result22 May, 06:45 pm IST
Score19 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags24 Apr 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens
Trend score and candlestick chart
56NeutralSMA20 +3.3% / mo · RSI overbought · MACD + · near 52W high
Stock trend: 61
Sector RS: 50
Sector 3M: -6.4% vs Nifty 500 -5.7%
Industrials FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
AMBANIORGOW candles · FIT view+44.6%Latest close ₹169.75 on 2026-10-12
Bar
+21.7%
RSI
75
MACD hist
3.91
52W pos
100%
2026-10-12O ₹139.50H ₹169.75L ₹136.00C ₹169.75Vol 74,000 sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
AMBANIORGONifty India ManufacturingNifty 500
- AMBANIORGO
- +50.9%
- Nifty 500
- -2.9%
- Nifty India Manufacturing
- -4.3%
- Vs Nifty 500
- +53.8 pp
Chart stats
16 Oct 2026- From 52W high
- +0.0%
- 52W range position
- 100%
- ATR (14)
- 2.8%
- Volume vs 20D
- 1.09x
- Avg traded value
- ₹0.3 Cr
- 20D price channel
- ₹110 - ₹169.8
₹169.8
₹94.9 - ₹169.8
₹4.7
Latest completed session
20-session average
47.5% annualized volatility
Research snapshot
What the evidence says now
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.
Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · OVERVALUED6
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Bad2
Revenue +79.7% · PAT -66.7% YoY
Technical
Neutral56
Price trend and sector-relative-strength timing.
Valuation
Legacy model-493.4%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence55
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 31 Mar 2026
Bad · 2/100PAT -67% YoY · margin compression · Rev +80% YoY · +20% QoQ
Filed 31 Mar 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹133 Cr | +79.7% | +19.8% |
| EBITDA | ₹8 Cr | NDF | +0.0% |
| Operating margin | 6.0% | NDF | -100 bps |
| PAT | ₹1 Cr | -66.7% | NDF |
| PAT margin | 0.8% | NDF | +75 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 37.50
- P/B
- 2.33
- EV/EBITDA
- 9.38
- Market Cap
- 147.00Cr
Profitability
- ROE
- 2.60%
- ROCE
- 10.60%
- ROA
- 1.89%
- Dividend Y
- —
Growth (CAGR)
- Revenue 5Y
- 23.00%
- EPS 5Y
- -4.00%
- Revenue 3Y
- 22.00%
- EPS 3Y
- -13.00%
Balance Sheet
- Debt/Equity
- 1.24
- Interest Coverage
- 2.22×
- Altman Z
- 2.20
- Book Value
- 73.00
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 4/5
- OCF
- —
- EPS TTM
- 5.48
Shareholding
- Promoter Hold
- 52.59%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 100%
Financial History
Updated 19/10/2026
Revenue
₹ CrLatest: 133+19.8% vs prev
Net Profit
₹ CrLatest: 1.0
ROE is shown only in the Annual view — quarterly equity data isn't published.
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Weekly technical trend read
Mixed signalsSignals are conflicting — long-term trend unclear. RSI 75. Wait for confirmation.
- SMA20 roughly flat — short-term momentum stalled.
- RSI(14) at 75 — overbought zone; risk of mean reversion.
- MACD above signal, histogram expanding — bullish momentum building.
- Within 3% of 52-week high — testing resistance.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
-
RS percentile
Insufficient history
1M return
+47.6%
3M return
+60.0%
6M return
-
1Y return
-
RS 1D
-
RS 20D
-
Sector rank
#2
Industry rank
#8
Stage evidence
- At least 170 daily sessions are required for the trend-stage read.
50-DMA
price above
200-DMA
unavailable
Sector
leading
Industry
leading
Relative-strength line vs Nifty 500 (base 100)
74 observations
16 Oct 2026Value 124.92+4.55%
RS vs Nifty 500125
Valuation & peers
U-Score 6 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Valuation & peers
U-Score 6 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
OVERVALUED
Fundamental score breakdown
U band · OVERVALUEDValuation2/30
Growth6/25
Quality1/20
Balance Sheet3/15
Cash Flow3/10
Piotroski
2/9 (+0)
Penalties
-9
Raw sum
6
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
6/100 · legacy band OVERVALUED
Positive drivers
- Cash flow contributes 3/10 to the score.
- Growth contributes 6/25 to the score.
- Balance sheet contributes 3/15 to the score.
Main drags
- Penalty bucket subtracts 9 points.
- Fair-value margin of safety is negative at -493.4%.
- Quality is weaker at 1/20; verify the latest quarterly trend.
Sector valuation model
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
37.5
PB
2.3
EV/EBITDA
9.4
ROE
2.6%
ROCE
10.6%
FCF Yield
—
Debt/Equity
1.2
MoS
-493.4%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE. Debt/equity is 1.2, so downturn resilience matters.
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 19 Oct 2026
v4.3-runtime-valuation
Final score
6
Previous: 6
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-493.4%
Previous: -465.3%
Score history
12 stored score snapshots. Latest stored move: +0 points.
19 Oct 2026
v4.3-runtime-valuation
8
8
8
8
8
8
8
8
6
6
6
6
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹94.87
-87.8% MoS
Growth-justified P/E
5.5
Growth-justified Value
₹30.03
-493.4% MoS
PEG
—
Comparable companies
Peers
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
DHARIWAL
SME
Dhariwalcorp Ltd.
Specialty Chemicals
match 158
8
35.6
11.0%
-279%
OVERVALUED
PARAGON
SME
Paragon Fine and Speciality Chemical Ltd.
Specialty Chemicals
match 156
58
10.9
9.6%
+72%
FAIR VALUE
RNPL
SME
Renol Polychem Ltd.
Specialty Chemicals
match 155
65
10.6
13.6%
+75%
UNDERVALUED
VSCL
SME
VADIVARHE SPECIALITY CHEMICALS LTD.
Specialty Chemicals
match 155
18
—
—
—
OVERVALUED
UNILEX
SME
Unilex Colours and Chemicals Ltd.
Specialty Chemicals
match 154
36
5.0
10.4%
+29%
WATCHLIST
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Ambani Orgochem Ltd. operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 31 Mar 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
55Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 16th percentile of the scored universe and 12th percentile within Industrials. Main check: results consistency is weak at 39/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
0 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
16th percentile
overall median 67 · Industrials: 12th pctile, median 68 · SME: 16th pctile, median 64
Evidence depth
Financial-only
0 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
60
acceptable · holding, pledge, alignment
Cash flow
67
acceptable · profit to cash conversion
Balance sheet
53
watch · leverage and solvency
Discipline
48
watch · capital discipline
Results
39
weak · quarterly consistency
Trust positives
- ▸Promoter pledge is zero.
- ▸4 years of positive FCF.
- ▸4/4 latest quarters had positive YoY revenue growth.
Trust risks
- ▸Promoter holding fell 8.7%.
- ▸2 latest quarters had PAT decline worse than 25% YoY.
- ▸Debt/equity is 1.29.
- ▸ROE is low at 2.5%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Ambani Orgochem Ltd.
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Annual reportSep 2026
Sep 2026 · Shareholders meeting 4 Sep - FY2025-26 annual report filed; 40th AGM on 26 Sep 2026; shareholders to approve director remuneration increases.
Source: Nse
Annual reportMar 2026
Mar 2026 · Annual Report 2026
Source: Nse
Annual reportMar 2025
Mar 2025 · Annual Report 2025
Source: Nse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.